Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13D/A - Evoke Pharma Inc | StockGist | StockGist

SCHEDULE 13D/A

Home Top Movers Companies Concepts

Home FilingsSCHEDULE 13D/A

SCHEDULE 13D/A

Beneficial Ownership

Amendment

Evoke Pharma Inc

Filed Dec 19, 2025

Accepted Dec 18, 2025, 7:00 PM ET

CIK 0001403708

View on SEC.gov

Beneficial Ownership Report

Active Investment

Reporting Person

Evoke Pharma Inc

Person Type

IA

Event Date

Dec 17, 2025

CUSIP: 30049G302

Amendment History

3 filings

SCHEDULE 13D
Original
Nov 12, 20250001651175-25-000007
SCHEDULE 13D/A
Amendment 1
Feb 3, 20250001104659-25-008666
SCHEDULE 13D/A
Amendment 2
Latest
Viewing
Dec 19, 20250001104659-25-123157

Recent Filings

Evoke Pharma Inc3 months ago

Evoke Pharma Inc4 months ago

Evoke Pharma Inc4 months ago

Evoke Pharma Inc4 months ago

Evoke Pharma Inc4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice